Australia markets close in 3 hours 47 minutes

Moleculin Biotech, Inc. (MBRX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.08+0.18 (+3.67%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
18,052
19,487
18,968
14,418
12,757
-
Selling general and administrative
9,773
10,017
11,542
8,386
6,785
-
Total operating expenses
27,954
29,631
30,640
22,968
19,742
-
Operating income or loss
-27,954
-29,631
-30,640
-22,968
-19,742
-
Total other income/expenses net
-87
-1,506
1,375
6,768
2,374
-
Income before tax
-26,824
-29,769
-29,025
-15,894
-17,355
-
Income tax expense
-
-
-
-
0
-229
Income from continuing operations
-26,824
-29,769
-29,025
-15,894
-17,355
-
Net income
-26,824
-29,769
-29,025
-15,894
-17,355
-
Net income available to common shareholders
-26,824
-29,769
-29,025
-15,894
-17,355
-
Basic EPS
-0.89
-15.15
-15.30
-8.85
-26.40
-
Diluted EPS
-0.89
-15.15
-15.30
-8.85
-26.40
-
Basic average shares
29,222
1,966
1,897
1,792
656.379
-
Diluted average shares
29,222
1,966
1,897
1,792
656.379
-